The stock of Cocrystal Pharma, Inc. (NASDAQ:COCP) is now priced at $1.06 and the shares are 0 points down or 0% lower compared to its previous closing price of $1.06. The stock had 1.823 million contracts set over the past session. COCP shares’ daily volume is compared to its average trading volume at 4.952 million shares. However, it has a float of 17.94 million and although its performance was -22.63% over the week, it’s one to watch. It means the stock’s downside potential is -100% with the COCP share price recently placing at $1.02 to $1.07. However, some brokerage firms have priced the stock below the average, including one that has called $5.
The shorts are climbing into the Cocrystal Pharma, Inc. stock, with the latest data on short interest released on August 14, 2020, showing that short interest numbers in the COCP shares have risen. Short interest in the stock represents just 4.19% of its float, but the volume has raised by 521032. The volume of shorted shares rised to 751248 from 230216 shares over the last two weeks. The average intraday trading volume has been 8.606 million shares, which means that days to cover moved to roughly 1.
In the last trading session, Cocrystal Pharma, Inc. (NASDAQ:COCP) dropped by -$0.31 over the week and lost -$1.3 on its 20-day. The stock’s high in the recent session is lower when compared to its 52-week high of $3.04. The stock recorded its established 52-week high on 08/04/20.
Since 12/18/19, the stock has traded to a low of $0.3861 at 174.54%, an encouraging piece of data likely to interest most investors out to exploit the stock’s recent surge. The stock has a beta allocation of -0.2. Being above 1 means that the stock’s volatility is higher than the market and traders are keenly watching it.
Looking at current readings, Cocrystal Pharma, Inc.’s two-week RSI is 28.43. This suggests that the stock is overbought at the moment and that COCP shares’ price movement remains not stable. The stochastic readings are equally revealing at 4.67% meaning the COCP share price is currently in overbought territory.
The technical chart shows that the COCP stock will likely settle at between $1.08 and $1.1 per share. However, if the stock dips below $1.03, then its market would become much weaker. Any downside could see the stock price sliding to levels as low as $1.
Currently, the stock is trading in the red of MACD, with a reading of -0.3611. Investors always pay attention to any move above or below the zero-line, mainly because the indicator points to the position of the stock’s short-term average relative to its long-term measure. A MACD -a reading above the zero line means that the short-term is above the long-term average. This scenario implies that there is an upward momentum. The opposite is true when the MACD falls below the zero-line.
Analysts at Maxim Group assigned COCP a rating of Buy in their intiating review released on July 08.
The average rating for the COCP equity is 2 and is currently gathering a bullish momentum. Of 2 analysts tracking Cocrystal Pharma, Inc. polled by Reuters, 0 rated COCP as a hold. The remaining 2 analysts were split evenly. However, the split wasn’t equal as a majority (2) rated it as a buy or strong buy. 0 analyst advised investors against buying the stock or to sell if they own any of the stock.